Zhihua Zhou

Zhihua Zhou

Auto-generated profile, based on publicly available information

Zhihua Zhou

Department of Neurology, The First Affiliated Hospital, School of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2014 in Critical Care
Verified
Journal Article
Open access
PDF file
YWYunfan Wu
Yunfan Wu
SZShusheng Zhou
Shusheng Zhou
ZZZhihua Zhou
Zhihua Zhou
BLBao Liu
Bao Liu
Introduction: The accurate assessment of intravascular volume status for the therapy of severe hypovolemia and shock is difficult and critical to critically ill patients. Non-invasive evaluation of fluid responsiveness by the rapid infusion of a very limited amount of volume is an important clinical goal. This study aimed to test whether echocardiographic parameters could predict fluid responsiveness in critically ill patients following a low-volume (50-ml crystalloid solution) infusion over 10 seconds. Methods: We prospectively studied 55 mechanically ventilated patients. Echocardiography was performed during a 50-ml infusion of crystalloid solution over 10 seconds and a further 450 ml over 15 minutes. Cardiac output (CO), stroke volume (SV), aortic velocity time index (VTI), and left ventricular ejection fraction (LVEF) were recorded. Patients were classified as responders (Rs) if CO increased by at least 15% following the 500-ml volume expansion or were classified as non-responders (NRs) if CO increased by less than 15%. Area under the receiver operating characteristic curves (AUC) compared CO variations after 50 ml over 10 seconds (∆CO50) and 500 ml over 15 minutes (∆CO500) and the variation of VTI after infusion of 50 ml of fluid over 10 seconds (∆VTI50). Results: In total, 50 patients were enrolled, and 27 (54%) of them were Rs. General characteristics, LVEF, heart rate, and central venous pressure were similar between Rs and NRs. In the Rs group, the AUC for ∆CO50 was 0.95 ± 0.03 (P <0.01; best cutoff value, 6%; sensitivity, 93%; specificity, 91%). Moreover, ∆CO50 and ∆CO500 were strongly correlated (r = 0.87; P <0.01). The AUC for ∆VTI50 was 0.91 ± 0.04 (P <0.01; best cutoff value, 9%; sensitivity, 74%; specificity, 95%). ∆VTI50 and ∆CO500 were positively correlated (r = 0.72; P <0.01). Conclusion: In critically ill patients, the variation of CO and VTI after the administration of 50-ml crystalloid solution over 10 seconds (∆CO50 and ∆VTI50) can accurately predict fluid responsiveness. Trial registration: Current Controlled Trials ISRCTN10524328. Registered 12 December 2013.

1 December 2019 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
DLDa-Ping Lyu
Da-Ping Lyu
YWYu Wang
Yu Wang
KWKai Wang
Kai Wang
MYMing Yao
Ming Yao
YWYun-Fan Wu
Yun-Fan Wu
ZZZhi-Hua Zhou
Zhi-Hua Zhou

29 July 2015 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
HWHonghao Wang
Honghao Wang
ZZZhihua Zhou
Zhihua Zhou
JHJiyuan Hu
Jiyuan Hu
YHYongzhu Han
Yongzhu Han
XWXun Wang
Xun Wang
RYRenmin Yang
Renmin Yang

11 January 2017 in Neurological Sciences
Verified
Journal Article
Closed access
ZZZhi-Hua Zhou
Zhi-Hua Zhou
YWYun-Fan Wu
Yun-Fan Wu
XWXuemin Wang
Xuemin Wang
YHYong-Zhu Han
Yong-Zhu Han

3 May 2019 in BMC Neurology
Verified
Journal Article
Open access
PDF file
ZZZhi-Hua Zhou
Zhi-Hua Zhou
YWYunfan Wu
Yunfan Wu
JCJin Cao
Jin Cao
JHJi-Yuan Hu
Ji-Yuan Hu
YHYong-Zhu Han
Yong-Zhu Han
XWXuemin Wang
Xuemin Wang
Wilson’s disease (WD) is an autosomal recessive disease of impaired copper metabolism. Previous study demonstrated that WD with corpus callosum abnormalities (WD-CCA) was limited to the posterior part (splenium). This study aimed to compare clinical features between WD-CCA and WD without corpus callosum abnormalities (WD-no-CCA). Forty-one WD patients who had markedly neurological dysfunctions were included in this study. We retrospectively reviewed clinical, biochemical characteristics and MRI findings in the 41 WD patients. All patients were assessed using the Unified Wilson’s Disease Rating Scale. Nine patients had corpus callosum abnormalities, 4 of 9 patients had abnormal signal in the genu and splenium, 5 of 9 patients had abnormal signal only in the splenium. WD-CCA had longer course (9.9 ± 4.0 years vs. 3.4 ± 3.6 years, p<0.01), more severe neurological dysfunctions (37.6 vs. 65.9, p<0.01) and higher psychiatric symptoms scores (11.2 vs. 22.5, p<0.01) than WD-no-CCA. The MRI findings indicated that WD-CCA had higher ratio than WD-no-CCA in globus pallidus (88.9% vs. 43.8%, p = 0.024) and thalamus (100% vs. 59.4%, p = 0.038). The index of liver function and copper metabolism had no significant in WD-CCA and WD-no-CCA patients. Our findings indicate Wilson’s disease can involve the posterior as well as the anterior part of CC and patients with CC involvement had more extensive brain lesions, more severe neurological dysfunctions and psychiatric symptoms.

24 April 2019 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
SLShuhu Liu
Shuhu Liu
ZZZhihua Zhou
Zhihua Zhou
LZLing Zhang
Ling Zhang
SMSiying Meng
Siying Meng
SLShuji Li
Shuji Li
XWXuemin Wang
Xuemin Wang
Sirtuin 2 (SIRT2) is thought to be important in the pathogenesis of Parkinson’s disease (PD), and the inhibition of SIRT2 rescues α-synuclein toxicity in a cellular model of PD. Recent studies have focused on identifying inhibitors of SIRT2, but little is known about the processes that directly regulate its function. GSK3β is a serine/threonine protein kinase that affects a wide range of biological functions, and it is localized in Lewy bodies (LBs). Therefore, we investigated whether SIRT2 is regulated by GSK3β and enhances cell death in PD. In the present study, Western blot showed that total SIRT2 levels did not change noticeably in a cellular model of PD but that SIRT2 phosphorylation was increased, and GSK3β activity was elevated. In addition, mass spectrometry (MS) studies indicated that SIRT2 was phosphorylated by GSK3β at three specific sites. Phospho- or dephospho-mimicking studies demonstrated that this postmodification (phosphorylation) increased SIRT2 toxicity in SH-SY5Y cells. Collectively, our findings identify a posttranslational mechanism that controls SIRT2 function in PD and provide evidence for a novel regulatory pathway involving GSK3β, SIRT2, and α-synuclein.